EUVIMEDEUVIMED entdecken
Open Access

Acetyl-cinobufagin suppresses triple-negative breast cancer progression by inhibiting the STAT3 pathway

Yufeng Qi, Haodong Wu, Tianru Zhu, Zitian Liu, Conghui Liu, Congzhi Yan, Zhixuan Wu, Yiying Xu, Ying Bai, Lehe Yang, Dezhi Cheng, Xiaohua Zhang und 3 weitere

Aging · 2023

DOI: 10.18632/aging.204967 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Yufeng Qi und 14 weiteren Autor:innen. Beteiligte Einrichtung: The First People’s Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou 311200, Zhejiang, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Bufanolides. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsBufanolidesAnimalsMiceHumansInterleukin-6PhosphorylationDisease Models, AnimalSTAT3 Transcription Factor

Stichwörter der Autor:innen

STAT3STAT3 inhibitoracetyl-cinobufaginepithelial-mesenchymal transitiontriple negative breast cancer

Substanzen

cinobufaginInterleukin-6BufanolidesSTAT3 protein, humanSTAT3 Transcription Factor

Autor:innen und Institutionen

  • The First People’s Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou 311200, Zhejiang, China.
  • The First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325000, Zhejiang, China.
  • Institute of Life Sciences, Biomedical Collaborative Innovation Center of Zhejiang Province, Wenzhou University, Wenzhou 325035, Zhejiang, China.
  • School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.

Zitieren

APA

Qi, Y., Wu, H., Zhu, T., Liu, Z., Liu, C., Yan, C., Wu, Z., Xu, Y., Bai, Y., Yang, L., Cheng, D., Zhang, X., Zhao, H., Zhao, C., & Dai, X. (2023). Acetyl-cinobufagin suppresses triple-negative breast cancer progression by inhibiting the STAT3 pathway. Aging. https://doi.org/10.18632/aging.204967

Vancouver

Qi Y, Wu H, Zhu T, Liu Z, Liu C, Yan C, et al. Acetyl-cinobufagin suppresses triple-negative breast cancer progression by inhibiting the STAT3 pathway. Aging. 2023. doi:10.18632/aging.204967

BibTeX
@article{Qi2023,
  author = {Qi, Yufeng and Wu, Haodong and Zhu, Tianru and Liu, Zitian and Liu, Conghui and Yan, Congzhi and Wu, Zhixuan and Xu, Yiying and Bai, Ying and Yang, Lehe and Cheng, Dezhi and Zhang, Xiaohua and Zhao, Haiyang and Zhao, Chengguang and Dai, Xuanxuan},
  title = {Acetyl-cinobufagin suppresses triple-negative breast cancer progression by inhibiting the STAT3 pathway},
  journal = {Aging},
  year = {2023},
  doi = {10.18632/aging.204967}
}
Kostenlos starten →